AstraZeneca signs deal for oral weight loss drug and lifts profit outlook

AstraZeneca signs deal for oral weight loss drug and lifts profit outlook

Anglo-Swedish drugmaker’s oncology and rare disease medication sales offset waning demand for Covid-19 jabs

Leave a Reply

Your email address will not be published. Required fields are marked *

Page Reader Press Enter to Read Page Content Out Loud Press Enter to Pause or Restart Reading Page Content Out Loud Press Enter to Stop Reading Page Content Out Loud Screen Reader Support
WordPress Cookie Plugin by Real Cookie Banner